GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Poly Medicure Ltd (NSE:POLYMED) » Definitions » EV-to-EBITDA

Poly Medicure (NSE:POLYMED) EV-to-EBITDA : 39.53 (As of May. 22, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Poly Medicure EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Poly Medicure's enterprise value is ₹165,831 Mil. Poly Medicure's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹4,195 Mil. Therefore, Poly Medicure's EV-to-EBITDA for today is 39.53.

The historical rank and industry rank for Poly Medicure's EV-to-EBITDA or its related term are showing as below:

NSE:POLYMED' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.94   Med: 32   Max: 74.35
Current: 39.53

During the past 13 years, the highest EV-to-EBITDA of Poly Medicure was 74.35. The lowest was 9.94. And the median was 32.00.

NSE:POLYMED's EV-to-EBITDA is ranked worse than
86.07% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.21 vs NSE:POLYMED: 39.53

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Poly Medicure's stock price is ₹1744.50. Poly Medicure's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹26.900. Therefore, Poly Medicure's PE Ratio for today is 64.85.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Poly Medicure EV-to-EBITDA Historical Data

The historical data trend for Poly Medicure's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poly Medicure EV-to-EBITDA Chart

Poly Medicure Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.18 32.30 35.09 29.63 36.05

Poly Medicure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.63 31.29 34.40 35.76 36.05

Competitive Comparison of Poly Medicure's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Poly Medicure's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poly Medicure's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Poly Medicure's EV-to-EBITDA falls into.



Poly Medicure EV-to-EBITDA Calculation

Poly Medicure's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=165830.599/4194.965
=39.53

Poly Medicure's current Enterprise Value is ₹165,831 Mil.
Poly Medicure's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,195 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poly Medicure  (NSE:POLYMED) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Poly Medicure's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1744.50/26.900
=64.85

Poly Medicure's share price for today is ₹1744.50.
Poly Medicure's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹26.900.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Poly Medicure EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Poly Medicure's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Poly Medicure (NSE:POLYMED) Business Description

Traded in Other Exchanges
Address
Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Poly Medicure (NSE:POLYMED) Headlines

No Headlines